-
Who we are
Who we are
Novavax is a global biotechnology company with a proven vaccine technology. We are focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health.
Discover our scienceLearn about our validated protein-based nanoparticle and Matrix-M™ adjuvant technology.
-
What we do
What we do
Novavax is focused on using our proven vaccine technology to help protect health through the development of our R&D assets and establishing partnerships
Latest UpdatesStay current with Novavax news as we make progress in discovering and developing innovative vaccines to help protect against serious infectious diseases.
-
Blog
Blog
Novavax is committed to accelerating the development of new and promising vaccines and sharing information based on years of study and experience.
Troy Morgan, JD
Senior Vice President
Deputy General Counsel & Chief Compliance Officer
Deputy General Counsel & Chief Compliance Officer
Mr. Morgan is senior vice president and deputy general counsel and chief compliance officer with responsibility for assisting in the development, management and oversight of its legal and compliance functions and leading efforts to facilitate legal and compliance requirements with emerging and complex healthcare laws and regulations. Prior to joining Novavax, Mr. Morgan was chief compliance officer for EMD Serono, Inc., and held senior global compliance roles at Merck KGaA, Sanofi, Biogen and Bioverativ. Mr. Morgan earned a Bachelor of Science from Troy University, Masters of Law from Pepperdine University, and a Juris Doctorate from Faulkner University’s Jones School of Law.